aTyr Pharma: EPS übertrifft Schätzungen

Investing.com – aTyr Pharma (NASDAQ: ) reported a quarter of EPS of -$0.230, versus analyst estimates of -$0.238.

If the last four years believe it is $60K, the cut-throat estimates will amount to $40K.

The Tyr Pharma stock has offered the official Trading at the closing price of 1.74$. In the last 3 months the performance was at minus -13,000%, in the last 12 months at minus -11,220%.

aTyr Pharma received in the last 90 days 1 positive EPS revision and 1 negative EPS revision. The early reactions of the action courses of Tyr Pharma on the advance payment of the business cheques can be a fact here.

InvestingPro supports the financing of Tyr Pharma on the Grundlage financing as “through-going”.

Information about the development of Tyr Pharma, where you can find the Bilanzkennzahlen, can be found here.

All balance dates and results can be found in our balance calendar, for a large number of companies in a real-time activated world.